[1]
Thewjitcharoen, Y. et al. 2023. Real-World Use of Once-Weekly Semaglutide in Thai Patients with Type 2 Diabetes Mellitus in a Private Hospital Setting. Journal of the ASEAN Federation of Endocrine Societies. 38, 1 (Mar. 2023), 21–28. DOI:https://doi.org/10.15605/jafes.038.01.11.